Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns.

Accused Gilgo Beach serial killer Rex Heuermann is expected to accept a plea deal in New York in more than a half dozen murders that spanned decades, according to reports. A source confirmed to Fox ...

Measuring cholesterol levels has long been the main way doctors assess the risk of heart disease. Increasingly, people are opting, too, for a simple, relatively affordable test: a coronary artery ...

Rex Heuermann, the alleged serial killer behind the infamous Gilgo Beach murders, is expected to enter a guilty plea in the murders during a court appearance next month, closing another chapter in the ...

Hudler will work roughly one-third of the Royals broadcasts this season. Hudler remains enthusiastic and will make his 2026 broadcast debut. Hudler is working with BelongKC on housing projects and ...

Suspected Gilgo Beach serial killer Rex Heuermann is expected to plead guilty to viciously murdering seven sex workers in a twisted case that has rocked Long Island for nearly two decades, according ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Accused Gilgo Beach serial killer Rex Heuermann is reportedly expected to flip his plea from not guilty to guilty in the ...

The accused Gilgo beach serial killer is expected to plead guilty during his next court appearance, according to two sources close to the case. Rex Heuermann had previously pleaded not guilty in the ...

While an engineering review showed no metaphorical meteor headed its way, Drumheller’s biggest dinosaur may still meet its extinction — at least where it now stands. A visual assessment conducted last ...

NEW YORK -- Alleged serial killer Rex Heuermann is next due to appear in court April 8, when it is anticipated he could change his plea to guilty and admit to the murders of women whose remains were ...

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The ...